Long-term impact of oral vancomycin, ciprofloxacin and metronidazole on the gut microbiota in healthy humans.


Journal

The Journal of antimicrobial chemotherapy
ISSN: 1460-2091
Titre abrégé: J Antimicrob Chemother
Pays: England
ID NLM: 7513617

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 29 08 2018
revised: 09 10 2018
accepted: 17 10 2018
pubmed: 13 11 2018
medline: 4 6 2020
entrez: 13 11 2018
Statut: ppublish

Résumé

The impact of combination antibiotic therapy on the composition of the intestinal microbiota remains ill-defined. We aimed to assess the effect of a 1 week antibiotic regimen on the intestinal microbiota of healthy humans for a period of up to 31 months. Thirteen healthy adult men received either no treatment or oral broad-spectrum antibiotics (ciprofloxacin, vancomycin and metronidazole) for 7 days. At four timepoints (prior to treatment, on day 9, day 49 and 8-31 months later) faecal samples were collected and analysed using 16S RNA gene sequencing. The short-term impact of broad-spectrum antibiotics on the gut microbiota was profound, with a loss of diversity and drastic shifts in community composition. In addition, antibiotics significantly reduced the abundance of bacterial taxa with important metabolic functions, such as the production of butyrate. The microbiota showed a remarkable return towards baseline after 8-31 months, but community composition often remained altered from its initial state. These findings suggest that combined treatment with vancomycin, ciprofloxacin and metronidazole has a profound and long-lasting effect on microbiota composition, the consequences of which remain largely unknown.

Identifiants

pubmed: 30418539
pii: 5173727
doi: 10.1093/jac/dky471
doi:

Substances chimiques

Anti-Bacterial Agents 0
Metronidazole 140QMO216E
Ciprofloxacin 5E8K9I0O4U
Vancomycin 6Q205EH1VU

Banques de données

ClinicalTrials.gov
['NCT02127749']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

782-786

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Bastiaan W Haak (BW)

Amsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam Infection & Immunity Institute, Meibergdreef 9, Amsterdam, The Netherlands.

Jacqueline M Lankelma (JM)

Amsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam Infection & Immunity Institute, Meibergdreef 9, Amsterdam, The Netherlands.

Floor Hugenholtz (F)

Amsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam Infection & Immunity Institute, Meibergdreef 9, Amsterdam, The Netherlands.

Clara Belzer (C)

Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands.

Willem M de Vos (WM)

Research Programs Unit Immunobiology, Department of Bacteriology and Immunology, Helsinki University, Helsinki, Finland.

W Joost Wiersinga (WJ)

Amsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam Infection & Immunity Institute, Meibergdreef 9, Amsterdam, The Netherlands.
Amsterdam UMC, University of Amsterdam, Department of Medicine, Division of Infectious Diseases, Meibergdreef 9, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH